• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

夏科氏关节病对侧足部的中期转归。

Midterm Fate of the Contralateral Foot in Charcot Arthropathy.

机构信息

Department of Orthopedic Surgery, Balgrist University Hospital, Zurich, Switzerland.

Unit for Clinical and Applied Research, Balgrist University Hospital, Zurich, Switzerland.

出版信息

Foot Ankle Int. 2020 Oct;41(10):1181-1189. doi: 10.1177/1071100720937654. Epub 2020 Jul 22.

DOI:10.1177/1071100720937654
PMID:32700577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8351021/
Abstract

BACKGROUND

The contralateral foot in Charcot arthropathy or neuroarthropathy (CN) is subject to increased plantar pressure. To date, the clinical consequences of this pressure elevation are yet to be determined. The aim of this study was to evaluate ulcer and amputation rates of the contralateral foot in CN.

METHODS

We abstracted the medical records of 130 consecutive subjects with unilateral CN. Rates of contralateral CN development and recurrence, contralateral ulcer development, and contralateral amputations were recorded. Statistical analysis was performed to identify possible risk factors for contralateral CN and ulcer development, and contralateral amputation. Mean follow-up was 6.2 (SD 4) years.

RESULTS

After a mean of 2.5 years, 19.2% patients developed contralateral CN. Female gender was associated with contralateral CN development (odds ratio 3.13, 95% confidence interval 1.27, 7.7). Overall, 46.2% patients developed a contralateral ulcer. Among the patients who developed contralateral CN, 60% developed an ulcer. Sanders type 2 at the index foot (midfoot CN) was significantly associated with contralateral ulcer development. Ulcer-free survival (UFS) differed significantly between patients with diabetes type 1 (median UFS 5131 days) and patients with diabetes type 2 (median UFS 2158 days). A total of 25 amputations had to be performed in 22 (16.9%) patients. Three of those 22 patients (2.3%) needed major amputation.

CONCLUSION

Almost 20% of patients developed contralateral CN. Nearly half of people with CN developed a contralateral foot ulceration. Patients with type 2 diabetes had significantly shorter UFS than patients with diabetes type 1. Every sixth patient needed an amputation, with the majority being minor amputations. The contralateral foot should be monitored closely and included in the treatment in patients with CN.

LEVEL OF EVIDENCE

Level IV, retrospective study.

摘要

背景

Charcot 关节病或神经关节病(CN)对侧足部的足底压力增加。迄今为止,这种压力升高的临床后果尚未确定。本研究旨在评估 CN 对侧足部溃疡和截肢的发生率。

方法

我们摘录了 130 例单侧 CN 连续患者的病历。记录对侧 CN 发展和复发、对侧溃疡发展和对侧截肢的发生率。进行统计学分析以确定对侧 CN 和溃疡发展以及对侧截肢的可能危险因素。平均随访 6.2(SD 4)年。

结果

平均 2.5 年后,19.2%的患者出现对侧 CN。女性与对侧 CN 发展相关(优势比 3.13,95%置信区间 1.27,7.7)。总体而言,46.2%的患者出现对侧溃疡。在出现对侧 CN 的患者中,60%出现溃疡。索引足(中足 CN)的桑德斯 2 型与对侧溃疡发展显著相关。溃疡无生存(UFS)在 1 型糖尿病患者(中位数 UFS 5131 天)和 2 型糖尿病患者(中位数 UFS 2158 天)之间有显著差异。22 名患者中有 25 名(16.9%)需要进行截肢,其中 3 名(2.3%)需要进行大截肢。

结论

近 20%的患者出现对侧 CN。近一半的 CN 患者出现对侧足部溃疡。2 型糖尿病患者的 UFS 明显短于 1 型糖尿病患者。每 6 名患者中就有 1 名需要截肢,其中大部分是小截肢。CN 患者应密切监测对侧足部并将其纳入治疗。

证据等级

IV 级,回顾性研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/ddf9659be905/nihms-1725242-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/41b0c69976d1/nihms-1725242-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/5a466cce3fc2/nihms-1725242-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/af55deccc1ab/nihms-1725242-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/110ad3b5ccf6/nihms-1725242-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/7e128db3bf15/nihms-1725242-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/ddf9659be905/nihms-1725242-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/41b0c69976d1/nihms-1725242-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/5a466cce3fc2/nihms-1725242-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/af55deccc1ab/nihms-1725242-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/110ad3b5ccf6/nihms-1725242-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/7e128db3bf15/nihms-1725242-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd0/8351021/ddf9659be905/nihms-1725242-f0006.jpg

相似文献

1
Midterm Fate of the Contralateral Foot in Charcot Arthropathy.夏科氏关节病对侧足部的中期转归。
Foot Ankle Int. 2020 Oct;41(10):1181-1189. doi: 10.1177/1071100720937654. Epub 2020 Jul 22.
2
Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients.糖尿病性神经病变性关节病(夏科氏关节病)采用骨科器械进行保护性完全负重治疗后的结果:单侧和双侧受累患者的比较
BMC Musculoskelet Disord. 2016 Dec 29;17(1):504. doi: 10.1186/s12891-016-1357-4.
3
Long-term follow-up of conservative treatment of Charcot feet.夏科氏足保守治疗的长期随访
Arch Orthop Trauma Surg. 2022 Oct;142(10):2553-2566. doi: 10.1007/s00402-021-03881-5. Epub 2021 Apr 7.
4
Comparison of Diabetic Charcot Patients With and Without Foot Wounds.有足部伤口和无足部伤口的糖尿病夏科氏关节病患者的比较。
Foot Ankle Int. 2017 Feb;38(2):140-148. doi: 10.1177/1071100716673985. Epub 2016 Oct 24.
5
No Difference in Risk of Amputation or Frequency of Surgical Interventions Between Patients With Diabetic and Nondiabetic Charcot Arthropathy.糖尿病性与非糖尿病性夏科氏关节病患者在截肢风险或手术干预频率方面无差异。
Clin Orthop Relat Res. 2023 Aug 1;481(8):1560-1568. doi: 10.1097/CORR.0000000000002546. Epub 2023 Jan 20.
6
Midfoot Charcot Neuro-arthropathy Precipitated by First or Fifth ray Amputation.第一跖骨或第五跖骨截肢引发的中足夏科氏关节病。
Foot Ankle Surg. 2021 Aug;27(6):673-676. doi: 10.1016/j.fas.2020.08.012. Epub 2020 Oct 11.
7
Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer.夏科氏关节病和糖尿病足溃疡后的下肢截肢风险。
Diabetes Care. 2010 Jan;33(1):98-100. doi: 10.2337/dc09-1497. Epub 2009 Oct 13.
8
Risk Factors Associated With Major Lower Extremity Amputation After Osseous Diabetic Charcot Reconstruction.骨糖尿病性夏科氏关节病重建术后下肢大截肢相关危险因素
J Foot Ankle Surg. 2019 Mar;58(2):295-300. doi: 10.1053/j.jfas.2018.08.059.
9
Prognostic Scoring System for Patients Undergoing Reconstructive Foot and Ankle Surgery for Charcot Neuroarthropathy: The Charcot Reconstruction Preoperative Prognostic Score.夏科特神经关节病足踝重建手术患者的预后评分系统:夏科特重建术前预后评分
J Foot Ankle Surg. 2018 May-Jun;57(3):451-455. doi: 10.1053/j.jfas.2017.10.021. Epub 2018 Mar 21.
10
Ostectomy and Medial Plantar Artery Flap Reconstruction for Charcot Foot Ulceration Involving the Midfoot.中足Charcot足溃疡的截骨术及足底内侧动脉皮瓣重建术
J Foot Ankle Surg. 2016 May-Jun;55(3):628-32. doi: 10.1053/j.jfas.2015.05.005. Epub 2015 Jul 16.

引用本文的文献

1
Factors associated with the development of recurrent and contralateral Charcot neuroarthropathy in individuals with diabetes mellitus: A scoping review.与糖尿病患者复发性和对侧夏科氏神经关节病发展相关的因素:范围综述。
J Foot Ankle Res. 2024 Dec;17(4):e70016. doi: 10.1002/jfa2.70016.
2
Foot Osteomyelitis Location and Rates of Primary or Secondary Major Amputations in Patients With Diabetes.足部骨髓炎糖尿病患者的原发性或继发性主要截肢部位和发生率。
Foot Ankle Int. 2022 Jul;43(7):957-967. doi: 10.1177/10711007221088552. Epub 2022 May 18.

本文引用的文献

1
Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer.糖尿病足并发症患者的 5 年死亡率和医疗费用直接堪比癌症。
J Foot Ankle Res. 2020 Mar 24;13(1):16. doi: 10.1186/s13047-020-00383-2.
2
Mid-term walking ability after Charcot foot reconstruction using the Ilizarov ring fixator.Charcot 足重建术后应用 Ilizarov 环形固定器的中期步行能力。
Arch Orthop Trauma Surg. 2020 Dec;140(12):1909-1917. doi: 10.1007/s00402-020-03407-5. Epub 2020 Mar 13.
3
Pressure distribution under the contralateral limb in Charcot arthropathy with different walking speeds.不同步行速度下夏科氏关节病对侧肢体的压力分布
Foot (Edinb). 2019 Jun;39:15-21. doi: 10.1016/j.foot.2019.01.008. Epub 2019 Jan 17.
4
Mortality and complications after treatment of acute diabetic Charcot foot.急性糖尿病性夏科足治疗后的死亡率和并发症。
J Diabetes Complications. 2018 Dec;32(12):1141-1147. doi: 10.1016/j.jdiacomp.2018.09.013. Epub 2018 Sep 29.
5
High Incidence of Recurrent Ulceration and Major Amputations Associated With Charcot Foot.与夏科氏足相关的复发性溃疡和大截肢发生率高。
J Foot Ankle Surg. 2018 Mar-Apr;57(2):301-304. doi: 10.1053/j.jfas.2017.10.008. Epub 2018 Jan 5.
6
Treatment of Charcot Neuroarthropathy and osteomyelitis of the same foot: a retrospective cohort study.同一足部夏科氏神经关节病与骨髓炎的治疗:一项回顾性队列研究。
BMC Musculoskelet Disord. 2017 Nov 16;18(1):460. doi: 10.1186/s12891-017-1818-4.
7
Gender Disparities in Osteoporosis.骨质疏松症中的性别差异
J Clin Med Res. 2017 May;9(5):382-387. doi: 10.14740/jocmr2970w. Epub 2017 Apr 1.
8
Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients.糖尿病性神经病变性关节病(夏科氏关节病)采用骨科器械进行保护性完全负重治疗后的结果:单侧和双侧受累患者的比较
BMC Musculoskelet Disord. 2016 Dec 29;17(1):504. doi: 10.1186/s12891-016-1357-4.
9
Comparison of Diabetic Charcot Patients With and Without Foot Wounds.有足部伤口和无足部伤口的糖尿病夏科氏关节病患者的比较。
Foot Ankle Int. 2017 Feb;38(2):140-148. doi: 10.1177/1071100716673985. Epub 2016 Oct 24.
10
The Charcot foot: pathophysiology, diagnosis and classification.夏科氏足:病理生理学、诊断与分类
Bone Joint J. 2016 Sep;98-B(9):1155-9. doi: 10.1302/0301-620X.98B9.37038.